Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of pharmaceuticals and agrochemicals. Its boronic acid group enables efficient carbon-carbon bond formation, particularly in the development of fluorinated heterocyclic compounds. Commonly applied in medicinal chemistry for constructing bioactive molecules, especially kinase inhibitors and other targeted therapies. The presence of fluorine and methyl groups enhances binding selectivity and metabolic stability in drug candidates. Also employed in the preparation of functional materials and ligands for catalysis.